Unique DUOX2+ACE2+ small cholangiocytes are pathogenic targets for primary biliary cholangitis
2023 · Nature Communications · 56 citations
https://doi.org/10.1038/s41467-022-34606-w
X
Xiaoxun Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
38
Papers
537
Citations
13
h-index
17
i10-index
Xiaoxun Zhang is an academic researcher from Army Medical University. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Drug Transport and Resistance Mechanisms & Pediatric Hepatobiliary Diseases and Treatments. The author has an h-index of 13, co-authored 33 publications.
ORCID: 0000-0002-3892-7464Papers by this author
worksIntegrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population
2024 · Science Translational Medicine · 32 citations
https://doi.org/10.1126/scitranslmed.adh9940
Semaphorin 7A interacts with nuclear factor NF-kappa-B p105 via integrin β1 and mediates inflammation
2023 · Cell Communication and Signaling · 15 citations
https://doi.org/10.1186/s12964-022-01024-w
Tumor necrosis factor α upregulates the bile acid efflux transporter OATP3A1 via multiple signaling pathways in cholestasis
2021 · Journal of Biological Chemistry · 12 citations
https://doi.org/10.1016/j.jbc.2021.101543
Hepatic interleukin 32 attenuates liver injury through repression of necroptosis in cholestasis
2023 · Journal of Digestive Diseases · 3 citations
https://doi.org/10.1111/1751-2980.13196
Hepatocyte-targeted hyaluronic acid-polyethyleneimine conjugates for acute liver injury therapy by ROS elimination and inflammation modulation
2023 · Materials & Design · 2 citations
https://doi.org/10.1016/j.matdes.2023.112212
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat